See also this year's filing and all EDGAR filings for this company.
PDF Report 0001796129_2021_Vincerx_Pharma_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001796129, Vincerx Pharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 63,110,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 82,000 |
| 4 | LiabilitiesCurrent | 5,505,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,598,000 |
| 9 | ResearchAndDevelopmentExpense | 7,116,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -8,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 63,192,000 |
| 1 | Liabilities | 5,505,000 |
| 2 | Expenses | 10,714,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 57,687,000 |
| 5 | NetIncome | -10,722,000 |
| 6 | ComprehensiveNetIncome | -10,722,000 |
| 7 | BaseVar | 39,709,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.35 |
| 9 | EconomicCapitalRatio | 3.92 |